Adult liver transplantation at UCL: update 2002

Acta Gastroenterol Belg. 2004 Apr-Jun;67(2):188-96.


The authors present the results of a single centre study of 587 liver transplants performed in 522 adults during the period 1984-2002. Results have improved significantly over time due to better pre-, peri- and post-transplant care. One, five, ten and fifteen year actuarial survivals for the whole patient group are 81.2; 69.8; 58.9 and 51.2%. The high incidence of de novo tumors (12.3%), of cardiovascular diseases (7.5%) and of end-stage renal function (3.6%) should be further incentives to tailor the immunosuppression to the individual patient and to direct the attention of the transplant physician to the long-term quality of life of the liver recipient.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Liver Transplantation*
  • Survival Analysis
  • Treatment Outcome


  • Immunosuppressive Agents